Keyword: United Kingdom

Near-term plans include the creation of a system for assessing study feasibility and an app to connect patients to studies.

The British government unveiled UCB’s investment in its second life science sector deal, which disclosed total spending of £1.3 billion.

The U.K. has been punching below its weight in attracting clinical research, and Brexit could provide an opportunity to remedy that, says ACRO.

Ian Hudson’s decision means the agency faces the prospect of changing leaders while dealing with the fallout from Brexit.

In rodent studies, exon skipping corrected a genetic error that's responsible for kidney disease linked to Joubert syndrome.

The U.K.’s Medicines Discovery Catapult is partnering with the National Centre for the Replacement, Refinement & Reduction of Animals in Research.

U.K. government committee calls for increased transparency following report that half of clinical trials fail to publish results.

AstraZeneca will collaborate with U.K. startup-supporter Medicines Discovery Catapult to develop the use of sound waves in mass spectrometry.

Visa denials for researchers trying to attend scientific meetings in the U.K. could ramp up after Brexit, the Wellcome Trust warned.

Pro-Remain politicians saw the reiteration of an old position as evidence that the split from the U.K. will decimate life science research.